Meeting
2023 ASCO Annual Meeting
A step toward genomic equity: Mutational profiling of patients with myeloid neoplasm in the largest minority-serving hospital in metropolitan Chicago.
Authors
Maha AT Elsebaie
John H. Stroger, Jr. Hospital of Cook County, Chicago, IL
Maha AT Elsebaie , Ekrem Turk , Vaishali Deenadayalan , Khaldun Obeidat , Ahmad Nanaa , Maryam Zia , Noah W. Birch
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Track
Hematologic Malignancies
Sub Track
Acute Leukemia
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 7037)
DOI
10.1200/JCO.2023.41.16_suppl.7037
Abstract #
7037
Poster Bd #
167
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Mutational landscape and clinical characterization of over 17,000 patients with myeloid malignancies using real-world data.
First Author: Taylor J. Jensen
Poster
2021 ASCO Annual Meeting
Prevalence of inferred clonal hematopoiesis (CH) detected on comprehensive genomic profiling (CGP) of solid tumor tissue or circulating tumor DNA (ctDNA).
First Author: Emmanuel S. Antonarakis
Poster
2020 ASCO Virtual Scientific Program
Type of prior genotoxic insult determines the genomic characteristics of therapy-related acute myeloid leukemia.
First Author: Michael Ozga
Poster
2019 ASCO Annual Meeting
Clonal hematopoiesis of indeterminate potential (CHIP) mutations in solid tumor malignancies.
First Author: Madison Conces